JavaScript seems to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.

Human Factor VII (Factor 7) Chromogenic AssaySense Activity Assay Kit

Human Factor VII (Factor 7) Chromogenic AssaySense Activity Assay Kit

Move your mouse over image or click to enlarge

Human Factor VII (Factor 7) Chromogenic AssaySense Activity Assay Kit

This assay employs a quantitative chromogenic activity technique that measures the specified antigen in samples.

View Datasheet

Cat#	Size	Price	Qty	Buy
CF1007	96 Well Plate	£402.19

Additional Information

Property	Value or Rating
Manufacturer	Assaypro, LLC.
Product Type	AssaySense Chromogenic Activity Kits
Samples	Serum, Cell Culture
Species	Human
Assay Format	Chromogenic Activity Assay
Product Size	96 Well Plate
Range	12.5 - 200 mIU/ml
Plex Number	1
Storage	Refer to component labels for details
Applications	Assay
Entrez Gene	2155
Omim	613878
UniProt	P08709
UniGene	Hs.36989
Special Notes	For Research Use Only, Not To Be Used For Diagnostic Purposes
References	* Koizume S et al. (2009) Hepatocyte Nuclear Factor-4-independent synthesis of coagulation factor VII in breast cancer cells and its inhibition by targeting selective histone acetyltransferases. Mol Cancer Res. 7(12): 1928-1936 * Fima UE et al. (2010) Long-Acting Coagulation Factors and Methods of Producing Same. Patent No: US 8476234 B2 * Krysiak R and Okopien B (2011) Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. Intern Med J. 41(6):473-481 * Momot AP et al. (2014) Allowable values of different parameters of hemostatic system in physiological pregnancy. Kazakhstan Association of Medical Laboratory Diagnostics 4(11):49-59 * Momot A at al. (2015) Dynamics of indicators of the hemostasis system in women during pregnancy and after childbirth. Laboratory Service. 2: 3-11. " title=" * Koizume S et al. (2009) Hepatocyte Nuclear Factor-4-independent synthesis of coagulation factor VII in breast cancer cells and its inhibition by targeting selective histone acetyltransferases. Mol Cancer Res. 7(12): 1928-1936 * Fima UE et al. (2010) Long-Acting Coagulation Factors and Methods of Producing Same. Patent No: US 8476234 B2 * Krysiak R and Okopien B (2011) Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. Intern Med J. 41(6):473-481 * Momot AP et al. (2014) Allowable values of different parameters of hemostatic system in physiological pregnancy. Kazakhstan Association of Medical Laboratory Diagnostics 4(11):49-59 * Momot A at al. (2015) Dynamics of indicators of the hemostasis system in women during pregnancy and after childbirth. Laboratory Service. 2: 3-11. " target="_blank"> * Koizume S et al. (2009) Hepatocyte Nuclear Factor-4-independent synthesis of coagulation factor VII in breast cancer cells and its inhibition by targeting selective histone acetyltransferases. Mol Cancer Res. 7(12): 1928-1936 * Fima UE et al. (2010) Long-Acting Coagulation Factors and Methods of Producing Same. Patent No: US 8476234 B2 * Krysiak R and Okopien B (2011) Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. Intern Med J. 41(6):473-481 * Momot AP et al. (2014) Allowable values of different parameters of hemostatic system in physiological pregnancy. Kazakhstan Association of Medical Laboratory Diagnostics 4(11):49-59 * Momot A at al. (2015) Dynamics of indicators of the hemostasis system in women during pregnancy and after childbirth. Laboratory Service. 2: 3-11.

Related Documents